This announcement is a separate document:
澳洋健康：国泰君安证券股份有限公司关于江苏澳洋健康产业股份有限公司重大资产出售之2023年度持续督导意见暨持续督导总结报告
Jiangsu Aoyang Health Industry: Guotai Junan Securities Co., Ltd.'s 2023 Continued Supervision Opinions and Continued Supervision Summary Report on the Sale of Major Assets of Jiangsu Aoyang Health Industry Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.